24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States.
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Flibanserin (Primary)
- Indications Decreased libido; Female sexual dysfunction
- Focus Therapeutic Use
- Acronyms SNOWDROP
- Sponsors Sprout Pharmaceuticals
- 16 May 2017 Results of a post-hoc analysis from three 24-week trials presented at the 112th Annual Meeting of the American Urological Association
- 02 Mar 2012 Company added in the association field as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History